FDA Investigates Avandia

The FDA is looking at whether the diabetes drug Avandia should stay on the market.

Avandia used to be one of GlaxoSmithKline's best-selling drugs, but studies have linked it to an increased risk of heart attack.

Government scientists have said the company's own study to demonstrate the drug's safety is "seriously flawed."

A panel of outside experts will recommend if Avandia needs a stronger warning label or to be pulled from the market.

Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
WTVY-TV 285 N Foster Street Dothan, AL 36303 334-792-3195
Copyright © 2002-2015 - Designed by Gray Digital Media - Powered by Clickability 98223759 - wtvy.com/a?a=98223759
Gray Television, Inc.